Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 169

1.

Hysterectomy-corrected cervical cancer mortality rates in Denmark during 2002-2015: A registry-based cohort study.

Hammer A, Kahlert J, Gravitt PE, Rositch AF.

Acta Obstet Gynecol Scand. 2019 Aug;98(8):1063-1069. doi: 10.1111/aogs.13608. Epub 2019 Apr 10.

PMID:
30868579
2.

Ultrahigh-Throughput Multiplexing and Sequencing of >500-Base-Pair Amplicon Regions on the Illumina HiSeq 2500 Platform.

Holm JB, Humphrys MS, Robinson CK, Settles ML, Ott S, Fu L, Yang H, Gajer P, He X, McComb E, Gravitt PE, Ghanem KG, Brotman RM, Ravel J.

mSystems. 2019 Feb 19;4(1). pii: e00029-19. doi: 10.1128/mSystems.00029-19. eCollection 2019 Jan-Feb.

3.

Whole tissue cervical mapping of HPV infection: Molecular evidence for focal latent HPV infection in humans.

Hammer A, de Koning MN, Blaakaer J, Steiniche T, Doorbar J, Griffin H, Mejlgaard E, Svanholm H, Quint WG, Gravitt PE.

Papillomavirus Res. 2019 Jun;7:82-87. doi: 10.1016/j.pvr.2019.02.004. Epub 2019 Feb 14.

4.

Limitations of simulation models for cervical cancer screening.

Hammer A, Landy R, Rositch AF, Gravitt PE.

Lancet Oncol. 2019 Feb;20(2):e68. doi: 10.1016/S1470-2045(19)30011-7. No abstract available.

PMID:
30712801
5.

Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy.

Brotman RM, Shardell MD, Gajer P, Fadrosh D, Chang K, Silver MI, Viscidi RP, Burke AE, Ravel J, Gravitt PE.

Menopause. 2018 Nov;25(11):1321-1330. doi: 10.1097/GME.0000000000001236.

PMID:
30358729
6.

How confident can we be in the current guidelines for exiting cervical screening?

Gravitt PE, Landy R, Schiffman M.

Prev Med. 2018 Sep;114:188-192. doi: 10.1016/j.ypmed.2018.07.005. Epub 2018 Jul 5.

PMID:
29981791
7.

Increases in Human Papillomavirus Vaccination Among Adolescent and Young Adult Males in the United States, 2011-2016.

Patel EU, Grabowski MK, Eisenberg AL, Packman ZR, Gravitt PE, Tobian AAR.

J Infect Dis. 2018 Jun 5;218(1):109-113. doi: 10.1093/infdis/jiy165.

8.

Classification and evolution of human papillomavirus genome variants: Alpha-5 (HPV26, 51, 69, 82), Alpha-6 (HPV30, 53, 56, 66), Alpha-11 (HPV34, 73), Alpha-13 (HPV54) and Alpha-3 (HPV61).

Chen Z, Schiffman M, Herrero R, DeSalle R, Anastos K, Segondy M, Sahasrabuddhe VV, Gravitt PE, Hsing AW, Chan PKS, Burk RD.

Virology. 2018 Mar;516:86-101. doi: 10.1016/j.virol.2018.01.002. Epub 2018 Jan 11.

9.

Uptake of HPV testing and extended cervical cancer screening intervals following cytology alone and Pap/HPV cotesting in women aged 30-65 years.

Silver MI, Rositch AF, Phelan-Emrick DF, Gravitt PE.

Cancer Causes Control. 2018 Jan;29(1):43-50. doi: 10.1007/s10552-017-0976-x. Epub 2017 Nov 9.

10.

Smoking and subsequent human papillomavirus infection: a mediation analysis.

Eldridge RC, Pawlita M, Wilson L, Castle PE, Waterboer T, Gravitt PE, Schiffman M, Wentzensen N.

Ann Epidemiol. 2017 Nov;27(11):724-730.e1. doi: 10.1016/j.annepidem.2017.10.004. Epub 2017 Oct 17.

11.

Unraveling the Epidemiology of Oral Human Papillomavirus Infection.

Gravitt PE.

Ann Intern Med. 2017 Nov 21;167(10):748-749. doi: 10.7326/M17-2628. Epub 2017 Oct 17. No abstract available.

PMID:
29049824
12.

Natural History of HPV Infection across the Lifespan: Role of Viral Latency.

Gravitt PE, Winer RL.

Viruses. 2017 Sep 21;9(10). pii: E267. doi: 10.3390/v9100267. Review.

13.
14.

Mechanistic mathematical models: An underused platform for HPV research.

Ryser MD, Gravitt PE, Myers ER.

Papillomavirus Res. 2017 Jun;3:46-49. doi: 10.1016/j.pvr.2017.01.004. Epub 2017 Feb 4. Review.

15.

Concordance of Penile and Oral Human Papillomavirus Infections Among Men in the United States.

Patel EU, Rositch AF, Gravitt PE, Tobian AAR.

J Infect Dis. 2017 Apr 15;215(8):1207-1211. doi: 10.1093/infdis/jix116.

16.

Human Papillomavirus: The Equal Opportunity Pathogen.

Gravitt PE.

J Infect Dis. 2017 Apr 1;215(7):1014-1016. doi: 10.1093/infdis/jix058. No abstract available.

17.

Hysterectomy-corrected cervical cancer mortality rates reveal a larger racial disparity in the United States.

Beavis AL, Gravitt PE, Rositch AF.

Cancer. 2017 May 15;123(6):1044-1050. doi: 10.1002/cncr.30507. Epub 2017 Jan 23.

18.

Trends and Determinants of Human Papillomavirus Concordance Among Human Immunodeficiency Virus-Positive and -Negative Heterosexual Couples in Rakai, Uganda.

Grabowski MK, Gravitt PE, Gray RH, Serwadda D, Redd AD, Kigozi G, Kong X, Nalugoda F, Wawer MJ, Quinn TC, Tobian AAR.

J Infect Dis. 2017 Mar 1;215(5):772-780. doi: 10.1093/infdis/jiw631.

19.

Prevalence of Anal High-Risk Human Papillomavirus Infections Among HIV-Positive and HIV-Negative Men Who Have Sex With Men in Nigeria.

Nowak RG, Gravitt PE, He X, Ketende S, Dauda W, Omuh H, Blattner WA, Charurat ME; TRUST Study Group.

Sex Transm Dis. 2016 Apr;43(4):243-8. doi: 10.1097/OLQ.0000000000000431.

20.

Eurogin Roadmap 2015: How has HPV knowledge changed our practice: Vaccines.

Brotherton JM, Jit M, Gravitt PE, Brisson M, Kreimer AR, Pai SI, Fakhry C, Monsonego J, Franceschi S.

Int J Cancer. 2016 Aug 1;139(3):510-7. doi: 10.1002/ijc.30063. Epub 2016 Mar 22. Review.

21.

Age-specific prevalence of HPV16/18 genotypes in cervical cancer: A systematic review and meta-analysis.

Hammer A, Rositch A, Qeadan F, Gravitt PE, Blaakaer J.

Int J Cancer. 2016 Jun 15;138(12):2795-803. doi: 10.1002/ijc.29959. Epub 2016 Jan 11. Review.

22.

Partner Human Papillomavirus Viral Load and Incident Human Papillomavirus Detection in Heterosexual Couples.

Grabowski MK, Kong X, Gray RH, Serwadda D, Kigozi G, Gravitt PE, Nalugoda F, Reynolds SJ, Wawer MJ, Redd AD, Watya S, Quinn TC, Tobian AA.

J Infect Dis. 2016 Mar 15;213(6):948-56. doi: 10.1093/infdis/jiv541. Epub 2015 Nov 23.

23.

Soil-Transmitted Helminth Infections Are Associated With an Increase in Human Papillomavirus Prevalence and a T-Helper Type 2 Cytokine Signature in Cervical Fluids.

Gravitt PE, Marks M, Kosek M, Huang C, Cabrera L, Olortegui MP, Medrano AM, Trigoso DR, Qureshi S, Bardales GS, Manrique-Hinojosa J, Cardenas AZ, Larraondo MA, Cok J, Qeadan F, Siracusa M, Gilman RH.

J Infect Dis. 2016 Mar 1;213(5):723-30. doi: 10.1093/infdis/jiv498. Epub 2015 Oct 20.

24.

HPV Seroprevalence in the United States: Behavior, Biology, and Prevention.

Gravitt PE.

J Infect Dis. 2016 Jan 15;213(2):171-2. doi: 10.1093/infdis/jiv405. Epub 2015 Aug 27. No abstract available.

25.

Prevalence and correlates of oral human papillomavirus infection among healthy males and females in Lima, Peru.

Rosen BJ, Walter L, Gilman RH, Cabrerra L, Gravitt PE, Marks MA.

Sex Transm Infect. 2016 Mar;92(2):149-54. doi: 10.1136/sextrans-2014-051942. Epub 2015 Aug 14.

26.

Seroepidemiology of Human Papillomavirus 16 (HPV16) L2 and Generation of L2-Specific Human Chimeric Monoclonal Antibodies.

Wang JW, Jagu S, Wu WH, Viscidi RP, Macgregor-Das A, Fogel JM, Kwak K, Daayana S, Kitchener H, Stern PL, Gravitt PE, Trimble CL, Roden RB.

Clin Vaccine Immunol. 2015 Jul;22(7):806-16. doi: 10.1128/CVI.00799-14. Epub 2015 May 13.

27.

Prevalence and correlates of HPV among women attending family-planning clinics in Thailand.

Marks MA, Gupta S, Liaw KL, Tadesse A, Kim E, Phongnarisorn C, Wootipoom V, Yuenyao P, Vipupinyo C, Rugpao S, Sriplienchan S, Gravitt PE, Celentano DD.

BMC Infect Dis. 2015 Mar 27;15:159. doi: 10.1186/s12879-015-0886-z.

28.

Global epidemiology of hysterectomy: possible impact on gynecological cancer rates.

Hammer A, Rositch AF, Kahlert J, Gravitt PE, Blaakaer J, Søgaard M.

Am J Obstet Gynecol. 2015 Jul;213(1):23-29. doi: 10.1016/j.ajog.2015.02.019. Epub 2015 Feb 25.

PMID:
25724402
29.

Patient concerns about human papillomavirus testing and 5-year intervals in routine cervical cancer screening.

Silver MI, Rositch AF, Burke AE, Chang K, Viscidi R, Gravitt PE.

Obstet Gynecol. 2015 Feb;125(2):317-29. doi: 10.1097/AOG.0000000000000638.

30.

Comparison of Hybribio GenoArray and Roche human papillomavirus (HPV) linear array for HPV genotyping in anal swab samples.

Low HC, Silver MI, Brown BJ, Leng CY, Blas MM, Gravitt PE, Woo YL.

J Clin Microbiol. 2015 Feb;53(2):550-6. doi: 10.1128/JCM.02274-14. Epub 2014 Dec 10.

31.

Oesophageal squamous cell carcinoma in high-risk Chinese populations: Possible role for vascular epithelial growth factor A.

Golozar A, Beaty TH, Gravitt PE, Ruczinski I, Qiao YL, Fan JH, Ding T, Tang ZZ, Etemadi A, Hu N, Hyland PL, Wang L, Wang C, Dawsey SM, Freedman ND, Abnet CC, Goldstein AM, Taylor PR.

Eur J Cancer. 2014 Nov;50(16):2855-65. doi: 10.1016/j.ejca.2014.07.022. Epub 2014 Aug 26.

32.

Human Leukocyte Antigen Class I and II Alleles and Cervical Adenocarcinoma.

Safaeian M, Johnson LG, Yu K, Wang SS, Gravitt PE, Hansen JA, Carrington M, Schwartz SM, Gao X, Hildesheim A, Madeleine MM.

Front Oncol. 2014 Jun 19;4:119. doi: 10.3389/fonc.2014.00119. eCollection 2014.

33.

Interplay between the temporal dynamics of the vaginal microbiota and human papillomavirus detection.

Brotman RM, Shardell MD, Gajer P, Tracy JK, Zenilman JM, Ravel J, Gravitt PE.

J Infect Dis. 2014 Dec 1;210(11):1723-33. doi: 10.1093/infdis/jiu330. Epub 2014 Jun 18.

34.

Evaluation of clinical performance of a novel urine-based HPV detection assay among women attending a colposcopy clinic.

Sahasrabuddhe VV, Gravitt PE, Dunn ST, Robbins D, Brown D, Allen RA, Eby YJ, Smith KM, Zuna RE, Zhang RR, Gold MA, Schiffman M, Walker JL, Castle PE, Wentzensen N.

J Clin Virol. 2014 Aug;60(4):414-7. doi: 10.1016/j.jcv.2014.04.016. Epub 2014 May 2.

35.

Increased age and race-specific incidence of cervical cancer after correction for hysterectomy prevalence in the United States from 2000 to 2009.

Rositch AF, Nowak RG, Gravitt PE.

Cancer. 2014 Jul 1;120(13):2032-8. doi: 10.1002/cncr.28548. Epub 2014 May 12.

36.

Seroprevalence of 8 oncogenic human papillomavirus genotypes and acquired immunity against reinfection.

Wilson L, Pawlita M, Castle PE, Waterboer T, Sahasrabuddhe V, Gravitt PE, Schiffman M, Wentzensen N.

J Infect Dis. 2014 Aug 1;210(3):448-55. doi: 10.1093/infdis/jiu104. Epub 2014 Feb 25.

37.

High-risk human papillomavirus viral load and persistence among heterosexual HIV-negative and HIV-positive men.

Grabowski MK, Gray RH, Serwadda D, Kigozi G, Gravitt PE, Nalugoda F, Reynolds SJ, Wawer MJ, Watya S, Quinn TC, Tobian AA.

Sex Transm Infect. 2014 Jun;90(4):337-43. doi: 10.1136/sextrans-2013-051230. Epub 2014 Jan 30.

38.

Cervical cancer screening in older women: new evidence and knowledge gaps.

Rositch AF, Silver MI, Gravitt PE.

PLoS Med. 2014 Jan;11(1):e1001586. doi: 10.1371/journal.pmed.1001586. Epub 2014 Jan 14. No abstract available.

39.

HPV self-testing and cervical cancer screening coverage.

Gravitt PE, Rositch AF.

Lancet Oncol. 2014 Feb;15(2):128-9. doi: 10.1016/S1470-2045(13)70605-3. Epub 2014 Jan 14. No abstract available.

PMID:
24433681
40.

Concordant Oral-Genital HPV Infection in South Africa Couples: Evidence for Transmission.

Vogt SL, Gravitt PE, Martinson NA, Hoffmann J, D'Souza G.

Front Oncol. 2013 Dec 12;3:303. doi: 10.3389/fonc.2013.00303. eCollection 2013.

41.

Comparison of human papillomavirus detections in urine, vulvar, and cervical samples from women attending a colposcopy clinic.

Sahasrabuddhe VV, Gravitt PE, Dunn ST, Brown D, Allen RA, Eby YJ, Smith K, Zuna RE, Zhang RR, Gold MA, Schiffman M, Walker JL, Castle PE, Wentzensen N.

J Clin Microbiol. 2014 Jan;52(1):187-92. doi: 10.1128/JCM.01623-13. Epub 2013 Nov 6.

42.

Microbiome, sex hormones, and immune responses in the reproductive tract: challenges for vaccine development against sexually transmitted infections.

Brotman RM, Ravel J, Bavoil PM, Gravitt PE, Ghanem KG.

Vaccine. 2014 Mar 20;32(14):1543-52. doi: 10.1016/j.vaccine.2013.10.010. Epub 2013 Oct 14.

43.

Characterizing the temporal dynamics of human papillomavirus DNA detectability using short-interval sampling.

Liu SH, Cummings DA, Zenilman JM, Gravitt PE, Brotman RM.

Cancer Epidemiol Biomarkers Prev. 2014 Jan;23(1):200-8. doi: 10.1158/1055-9965.EPI-13-0666. Epub 2013 Oct 15.

44.

Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy.

Brotman RM, Shardell MD, Gajer P, Fadrosh D, Chang K, Silver MI, Viscidi RP, Burke AE, Ravel J, Gravitt PE.

Menopause. 2014 May;21(5):450-8. doi: 10.1097/GME.0b013e3182a4690b.

45.

Comparison of the immune microenvironment of the oral cavity and cervix in healthy women.

Fakhry C, Marks MA, Gilman RH, Cabrerra L, Yori P, Kosek M, Gravitt PE.

Cytokine. 2013 Nov;64(2):597-604. doi: 10.1016/j.cyto.2013.08.009. Epub 2013 Sep 7.

46.

Evolution and taxonomic classification of alphapapillomavirus 7 complete genomes: HPV18, HPV39, HPV45, HPV59, HPV68 and HPV70.

Chen Z, Schiffman M, Herrero R, DeSalle R, Anastos K, Segondy M, Sahasrabuddhe VV, Gravitt PE, Hsing AW, Burk RD.

PLoS One. 2013 Aug 16;8(8):e72565. doi: 10.1371/journal.pone.0072565. eCollection 2013.

47.

Menstrual cycle and detectable human papillomavirus in reproductive-age women: a time series study.

Liu SH, Brotman RM, Zenilman JM, Gravitt PE, Cummings DA.

J Infect Dis. 2013 Nov 1;208(9):1404-15. doi: 10.1093/infdis/jit337. Epub 2013 Jul 24.

48.

Growing evidence that HPV infection is associated with an increase in HIV acquisition: exploring the issue of HPV vaccination.

Rositch AF, Gravitt PE, Smith JS.

Sex Transm Infect. 2013 Aug;89(5):357. doi: 10.1136/sextrans-2012-050870. No abstract available.

PMID:
23858496
49.

Obesity and human papillomavirus infection in perimenopausal women.

Liu SH, Rositch AF, Viscidi RP, Silver MI, Burke AE, Gravitt PE.

J Infect Dis. 2013 Oct 1;208(7):1071-80. doi: 10.1093/infdis/jit297. Epub 2013 Jul 9.

50.

Trends in head and neck cancers in Peru between 1987 and 2008: Experience from a large public cancer hospital in Lima.

Walter L, Vidaurre T, Gilman RH, Poquioma E, Olaechea C, Gravitt PE, Marks MA.

Head Neck. 2014 May;36(5):729-34. doi: 10.1002/hed.23369. Epub 2013 Sep 2.

Supplemental Content

Loading ...
Support Center